Pfizer (NYSE: PFE) reported Q4 EPS of $0.66, $0.08 better than the analyst estimate of $0.58. Revenue for the quarter came in at $17.58 billion versus the consensus estimate of $16.91 billion.

GUIDANCE:

Pfizer sees FY2026 EPS of $2.80-$3.00, versus the consensus of $2.97. Pfizer sees FY2026 revenue of $59.5-62.5 billion, versus the consensus of $61 billion.

For earnings history and earnings-related data on Pfizer (PFE) click here.